|
ZNF382 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94577687295805E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.60009808023187E-11 |
| Normal-vs-Stage2 |
2.593000E-04 |
| Normal-vs-Stage3 |
7.54174500627869E-13 |
| Normal-vs-Stage4 |
3.24170024157411E-10 |
| Stage1-vs-Stage2 |
1.528180E-01 |
| Stage1-vs-Stage3 |
5.722000E-02 |
| Stage1-vs-Stage4 |
1.556150E-01 |
| Stage2-vs-Stage3 |
1.051890E-02 |
| Stage2-vs-Stage4 |
2.701900E-02 |
| Stage3-vs-Stage4 |
9.803800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39031017201796E-13 |
| Normal-vs-AfricanAmerican |
1.56634999999294E-05 |
| Normal-vs-Asian |
3.86589999999964E-05 |
| Caucasian-vs-AfricanAmerican |
9.490000E-01 |
| Caucasian-vs-Asian |
7.458500E-02 |
| AfricanAmerican-vs-Asian |
2.643000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0430002134475E-10 |
| Normal-vs-Female |
3.08086889333481E-12 |
| Male-vs-Female |
7.227200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.34300348619831E-11 |
| Normal-vs-Age(41-60Yrs) |
3.50879991728448E-10 |
| Normal-vs-Age(61-80Yrs) |
1.01139999708622E-08 |
| Normal-vs-Age(81-100Yrs) |
2.36080000000083E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.716400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.940400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.398550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.335400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.894230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.311020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.156380E-01 |
| Classical-VS-Follicular |
4.642200E-01 |
| Classical-VS-Other |
5.060400E-01 |
| Classical-VS-Normal |
2.18358664483276E-12 |
| Tall-VS-Follicular |
5.589800E-02 |
| Tall-VS-Other |
8.723600E-01 |
| Tall-VS-Normal |
8.96959995166924E-09 |
| Follicular-VS-Other |
2.170000E-01 |
| Follicular-VS-Normal |
1.78869999999387E-05 |
| Other-VS-Normal |
1.297890E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.58775248293841E-12 |
| Normal-vs-N1 |
1.50349999117338E-09 |
| N0-vs-N1 |
6.620800E-01 |
|
|
